ImmuCell enters new employment agreements with CFO, SVP; grants stock options

IMMUCELL CORP /DE/

CFO Fiori base salary $315k, target bonus 50% of base, option for 120k shares at $6.26.
SVP Brockmann base salary $300k, same bonus structure, option for 100k shares.
CEO te Boekhorst gets performance-based option for 110k shares, vests only if 4-quarter net operating income ≥ 300% of FY2025 audited NOI.
Options vest in 3 equal annual installments starting Jan 2027, expire 10 years, subject to change-of-control acceleration.
Effective January 27, 2026; agreements include clawback and severance provisions.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.